04/01/2017
Zealand reports that Sanofi announces Soliqua™ 100/33 now available in the U.S
Zealand Pharma (Zealand) reports that Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide 33 mcg/mL injection) is now available by prescription in U.S. pharmacies. Soliqua 100/33 is indicated for the treatment of adults [...]
